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Abstract
Bovine African Trypanosomosis is an infectious parasitic disease affecting livestock produc-
tivity and thereby impairing the economic development of Sub-Saharan Africa. The most
important trypanosome species implicated is T. congolense, causing anemia as most impor-
tant pathological feature. Using murine models, it was shown that due to the parasite’s effi-
cient immune evasion mechanisms, including (i) antigenic variation of the variable surface
glycoprotein (VSG) coat, (ii) induction of polyclonal B cell activation, (iii) loss of B cell mem-
ory and (iv) T cell mediated immunosuppression, disease prevention through vaccination
has so far been impossible. In trypanotolerant models a strong, early pro-inflammatory
immune response involving IFN-γ, TNF and NO, combined with a strong humoral anti-VSG
response, ensures early parasitemia control. This potent protective inflammatory response
is counterbalanced by the production of the anti-inflammatory cytokine IL-10, which in turn
prevents early death of the host from uncontrolled hyper-inflammation-mediated immunopa-
thologies. Though at this stage different hematopoietic cells, such as NK cells, T cells and B
cells as well as myeloid cells (i.e. alternatively activated myeloid cells (M2) or Ly6c- mono-
cytes), were found to produce IL-10, the contribution of non-hematopoietic cells as potential
IL-10 source during experimental T. congolense infection has not been addressed. Here,
we report for the first time that during the chronic stage of T. congolense infection non-
hematopoietic cells constitute an important source of IL-10. Our data shows that hepato-
cyte-derived IL-10 is mandatory for host survival and is crucial for the control of trypanoso-
mosis-induced inflammation and associated immunopathologies such as anemia,
hepatosplenomegaly and excessive tissue injury.
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Author summary
Bovine African Trypanosomosis is a parasitic disease of veterinary importance that
adversely affects the public health and economic development of sub-Saharan Africa. The
most important trypanosome species implicated is T. congolense, causing anemia as most
important pathological feature and major cause of death. Using murine models, it was
shown that the disease is characterized by a well-timed and balanced production of pro-
inflammatory cytokine promoting factors followed by an anti-inflammatory response,
involving IL-10. The latter is required to attenuate infection-associated pathogenicity and
to prevent early host death from uncontrolled hyper-inflammation mediated immunopa-
thologies. However, the cellular source of IL-10 in vivo and the window within which
these cells exert their function during the course of African trypanosomiasis remain
poorly understood, which hampers the design of effective therapeutic strategies. Using a
T. congolense infection mouse model, relevant for bovine trypanosomosis, we demonstrate
that during the chronic stage of infection hepatocyte-derived IL-10, but not myeloid cell-
derived IL-10, regulates the main infection-associated immunopathologies and ultimately
mediates host survival. Hence, strategies that tilt the balance of hepatocyte cytokine pro-
duction in favor of IL-10 could majorly impact the wellbeing and survival of T. congo-
lense-infected animals. Given the unmet medical need for this parasite infection, our
findings offer promise for improved treatment protocols in the field.
Introduction
African trypanosomes are extracellular protozoan parasites transmitted by the bite of infected
tsetse flies (genus Glossina), causing sleeping sickness in humans and Nagana disease in cattle in
sub-Saharan Africa. About 60 million people are at risk and Nagana causes three million cattle
deaths every year due to fever, weight loss and anemia. By affecting the agricultural production
and animal husbandry, Animal African trypanosomosis (AAT) has a high socio-economic
impact in vast areas of the tropics and subtropics where the transmission occurs [1–3]. As such,
it is considered to be the livestock disease with the highest impact on agricultural production
and animal husbandry in Africa, whereby the annual economic loss in livestock production is
estimated at 4 billion US$ [1]. Trypanosoma congolense is considered to be the most pathogenic
trypanosome species in cattle [4]. Although anemia is the most prominent pathological feature
of AAT [2,5], sporadic episodes of fever as well as leukopenia, weight loss and hepatosplenome-
galy, in conjunction with appetite loss, lethargy and emaciation, can contribute to death through
eventual congestive heart failure. Importantly, trypanotolerance in cattle has been described as
the capacity of an animal to better control parasitaemia and to have a better capacity to limit
anemia development and weight loss, whereby anaemia control is more important for survival
and productivity than parasite control [5,6]. Murine models are considered valuable tools to
study the interactions between parasites and hosts that contribute to immuno-pathogenicity
and allow discriminating between trypanosusceptible versus trypanotolerant animals. Experi-
mental T. congolense infections in mice have shown that C57BL/6 mice are able to control the
first peak of parasitemia and develop a chronic infection lasting for 4 months, and are therefore
considered as relatively trypanotolerant animals [7], while trypanosusceptible BALB/c mice die
within 10 days post infection [7]. The infection is characterized by two stages; during the early
stage there is a strong inflammatory immune response mediated by T cells and involving classi-
cally IFN-γ-activated myeloid cells (so-called M1) required for the efficient control of the first
most prominent parasitemia peak through their production of trypanotoxic molecules, such as
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nitric oxide (NO) and Tumor Necrosis Factor (TNF), and the phagocytosis of antibody-opso-
nized parasites that occurs mainly in the liver [8–12]. This is followed by the production of the
anti-inflammatory cytokine IL-10, which is essential to dampen the inflammatory immune
response after parasitemia has been cleared and to prevent tissue damage as well as death of the
host due to a hyper-inflammation syndrome [13–16]. Hence, IL-10 allows the development of a
so-called ‘‘trypanotolerant” phenotype [11,17]. Accordingly, IL-10-deficient C57BL/6 mice
infected with T. congolense develop a severe inflammatory response-like syndrome due to exces-
sive production of inflammatory cytokines such as TNF and IFN-γ, resulting in a drastic reduc-
tion in survival time [14,17–19]. Conversely, absence of the upstream regulator of the
inflammatory cascade, i.e. macrophage migration inhibitory factor (MIF), has been shown to
correlate with an attenuated inflammatory immune response and a concordantly reduced
immunopathology during the course of infection, which is associated with an extended survival
time [20]. This phenotype coincides with increased systemic levels of IL-10 during the later
stages of infection [20]. Hence, a well-timed and balanced order of pro-inflammatory cytokine
promoting factors followed by an anti-inflammatory response is required to attenuate infec-
tion-associated pathogenicity. However, the in vivo cellular source of IL-10 and the window
within which these cells exert their function during the course of African trypanosomiasis, as
well as the associated molecular mechanism(s) implicated in its production, remain poorly
understood. Hence, knowledge about the inflammation resolution process is necessary to
understand the host-parasite interplay and might pave the way to improve or develop more effi-
cient therapies that reduce the devastating effect of chronic protozoan infections [21].
Here, we aimed at refining the cellular contribution of IL-10 during experimental African
trypanosomiasis using the T. congolense model in C57BL/6 mice. Thus far, both naturally occur-
ring CD4+ Foxp3+ Tregs as well as myeloid cells (Ly6C- patrolling monocytes and alternatively
activated macrophages (M2)) were found to be sources of IL-10, that limit to some extent the
development of immuno-pathogenicity (including liver injury) during infection [14,15,19].
However, it remains unclear if non-hematopoietic cells, such as hepatocytes, could also be a
potential source of IL-10 during the course of the infection. Using IL-10 reporter mice, we con-
firmed that hepatocytes can produce IL-10 upon exposure to T. congolense parasites or parasite-
derived products in vitro as well as during T. congolense infection. Therefore, we investigated
the in vivo anti-inflammatory potential of hepatocyte-derived IL-10 during T. congolense infec-
tion, using hepatocyte-specific IL-10-deficient mice. We demonstrate that hepatocyte-derived
IL-10 regulates the main infection-associated immunopathologies, such as anemia, weight loss,
chronic systemic inflammation, hepatosplenomegaly and liver damage during chronic infection
with T. congolense. Hence, although other cells can produce IL-10 during experimental T. con-
golense infection, hepatocyte-derived IL-10 is crucial to control inflammation-induced immu-
nopathogenicity during the chronic stage of infection that ultimately mediates host survival.
Results
Hepatocyte-specific IL10-deficiency correlates with reduced survival,
increased tissue pathogenicity and increased systemic inflammation during
T. congolense infection
Considering the essential role of IL-10 in limiting the pathogenicity and, thus, the susceptibility
to infection, we evaluated if besides leukocytes (i.e. regulatory T cells and myeloid cells) also
hepatocytes could be a potential source of IL-10 during African trypanosome infection. There-
fore, we investigated in more detail the role of hepatocyte-derived IL-10 in the outcome of
experimental T. congolense infection, a model in which the systemic levels of IL-10 progressively
increase during the course of infection in order to sustain host survival [19]. Using IL-10-eGFP
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reporter (Vert-X) mice, we confirmed that besides leukocytes (S1 Fig), also hepatocytes from
chronically T. congolense infected animals can produce IL-10 (Fig 1A–1C). In addition, IL-10
was detected in the supernatant of hepatocyte cultures from chronically T. congolense infected
wild type (WT) but not hepatocyte-specific IL-10-deficient (TgAlbCre-IL10-/-) mice (Fig 1D).
Interestingly, induction of IL-10 was observed in in vitro cultures of hepatocytes from non-
infected WT mice stimulated with either trypanosomes or trypanosome lysate, as well as soluble
VSG (sVSG) (Fig 1E), indicating a direct parasite effect. Finally, isolated hepatocytes from
chronically T. congolense infected WT mice exhibited, besides an increase in IL-10 gene expres-
sion, also an increased IL-10r expression compared to hepatocytes from uninfected animals (Fig
1F–1G). In contrast, no increase in IL-10r expression was observed in isolated hepatocytes from
chronically T. congolense infected TgAlbCre-IL10-/- mice compared to hepatocytes from unin-
fected animals (Fig 1G).
Since myeloid cells could also be a source of IL-10 in infected animals [15], we included in
subsequent experiments myeloid-specific IL-10-deficient (LysM-IL-10-/-) mice and compared
their infection parameters to TgAlbCre-IL10-/- and WT controls. Although early peak parasite-
mia was similar in all mouse strains, TgAlbCre-IL10-/- mice exhibited significantly higher
parasitemia levels during the later stage of infection as well as an increased weight gain (due to
increased spleen and liver weight), more severe anemia and a significantly reduced median
survival time (Fig 2A–2D, median survival time WT: 102 ± 26; LysM-IL-10-/-: 100 ± 14,
TgAlbCre-IL10-/: 50 ± 10 days). To confirm that the observed differences were not due to
intrinsic gross abnormalities in the TgAlbCre-IL10-/- mice, these mice were infected with
another strain of trypanosomes, namely T. brucei, which induces a more acute infection with
low systemic levels of IL-10 [22,23]. As shown in S2 Fig, compared to WT mice, TgAlbCre-
IL10-/- mice exhibited a similar parasitemia, anemia and weight loss profile and had a similar
survival profile in this model.
In order to delineate the window within which the contribution of hepatocyte IL-10 plays a
role, a kinetic study was performed in these 3 different mouse lines, whereby the blood was
investigated with respect to cytokines and white blood cell (WBC) composition (see gating
strategy S3A Fig) that can contribute to pathogenicity. As shown in Fig 3, TgAlbCre-IL10-/-
mice exhibited similar early cytokine levels as WT and LysM-IL-10-/- mice. Yet, between 38–
48 days post infection, all tested pro-inflammatory cytokines (IFN-γ, TNF, IL-6 and MIF)
increased or remained high in TgAlbCre-IL10-/- mice, but not in the other strains.
At the level of the WBCs, we observed a progressive increase in the percentage of CD45+
cells during the course of infection in all groups of mice (Fig 4A). A gradual decrease in the
absolute number of B cells (per mL blood) was observed in all groups of mice, yet TgAlbCre-
IL10-/- mice exhibited significantly lower numbers of B cells between day 38–48 post infection
compared to WT and LysM-IL-10-/- mice (Fig 4B). At the level of the T cells, no differences
were recorded for any of the groups. Regarding the Ly6Chigh monocytes, which play a key role
in pathogenicity development, we observed a similar increase in all groups as the infection pro-
gresses, whereby these cells already exhibited a significant upregulation of MHC-II at day 7 p.i.
Interestingly, at the later stages of infection their MHC-II expression was significantly higher in
TgAlbCre-IL10-/- mice compared to WT and LysM-IL-10-/- mice (Fig 4C), indicative of a higher
monocyte activation level. Likewise, the number of polymorphonuclear cells (PMN), which
were also documented to contribute to trypanosome-infection associated pathogenicity [22],
were found to progressively increase in all groups as the infection progresses, yet reaching sig-
nificantly higher levels in TgAlbCre-IL10-/- mice at the later infection stages than in WT and
LysM-IL-10-/- mice (Fig 4B). Finally, the number of Ly6Clow patrolling monocytes, which were
documented to attenuate tissue injury [24], significantly dropped in TgAlbCre-IL10-/- mice at
later infection stages (Fig 4B). Overall, TgAlbCre-IL10-/- mice clearly display an increased
Hepatocyte-IL-10 attenuates African trypanosomiasis-associated pathogenicity
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1008170 February 3, 2020 4 / 29
inflammatory immune response at later stages of T. congolense infection, coinciding with
reduced B cell and patrolling monocyte numbers that are required for parasite control and
attenuation of tissue injury, respectively.
Since the largest differences in pathogenicity (i.e. anemia and weight change) and blood
parameters were established between 38–48 days post infection, a more refined analysis was
performed around day 45 post T. congolense infection. This time point was selected for all fur-
ther experiments. Considering the crucial role of IL-10 in attenuating the pathogenic effects of
pro-inflammatory cytokines, the reduced survival of TgAlbCre-IL10-/-mice could be due to a
higher tissue pathogenicity in association with higher levels of these cytokines [14,19]. In
agreement, as compared to WT and LysM-IL-10-/- mice, TgAlbCre-IL10-/- mice exhibited
Fig 1. Hepatocytes from chronically T. congolense infected mice are proficient IL-10 producing cells and hepatocytes from
non-infected animals can be triggered by trypanosomes to produce IL-10. Representative FACS profile of purified
hepatocytes at day 45 post T. congolense infection showing an FSC-A versus SSC-A plot (A) and a CD45 versus FSC-A (B) plot
(revealing a purity of more than 95%), whereby hepatocytes were selected based on their CD45- profile. Of note, the selection of
the hepatocytes (CD45- cells) is based on the gating strategy used in S1A Fig, whereby debris/death cells can be excluded. (C)
Histogram plot showing the intensity of the IL-10-eGFP signal in hepatocytes from IL-10-eGFP reporter (blue) mice and, as
negative control, in hepatocytes from TgAlbCre-IL10-/- (red) mice. At day 45 post T. congolense infection, isolated hepatocytes
from WT (black symbol) and TgAlbCre-IL10-/- (white symbol) mice were cultured for 36 hours and subsequently tested in
ELISA for IL-10 protein levels (D). IL-10 secretion by purified hepatocytes from naïve WT (black bar) following stimulation
with 107 parasites or 50 μg lysate or 5 μg sVSG for 36 hours at 37˚C in a 5% CO2 incubator (E). For each condition 2.106 liver
cells per ml were used. As controls cells were left untreated. Results are representative of 2 independent experiments and shown
as mean of 3 individual mice ± SEM. At day 45 post T. congolense infection, isolated hepatocytes from WT (black symbol) and
TgAlbCre-IL10-/- (white symbol) mice, were tested in RT-PCR for IL-10 and IL-10R gene expression (F and G, respectively). Of
note, RT-PCR results are presented as fold change whereby the expression levels were normalized using S12 and expressed
relatively to the expression levels in the corresponding non-infected animals. Non-infected animals as well as TgAlbCre-IL10-/-
mice did not show any detectable IL-10 protein levels (Dashed line). Data are represented as mean of at least 3–5 mice per
group ± SEM and are representative of 2 independent experiments. (�: p�0.05, ��: p�0.01, ND: Not detected).
https://doi.org/10.1371/journal.ppat.1008170.g001
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Fig 2. Hepatocyte-specific IL10-deficiency correlates with reduced survival and increased anemia during T. congolense
infection. A) Parasitemia, (B) Survival, (C) weight change and (D) anemia of T. congolense infected wild type (WT, black
symbol), LysM-IL-10-/- (white symbol) and TgAlbCre-IL10-/- (red symbol) mice. Data are represented as mean (A, C-D) or
median (B) of 3–5 mice per group ± SEM and are representative of 2–3 independent experiments. (�: p�0.05, ��: p�0.01).
https://doi.org/10.1371/journal.ppat.1008170.g002
Fig 3. Hepatocyte-specific IL10-deficiency correlates with increased pro-inflammatory serum cytokine levels during the
chronic stage of T. congolense infection. Serum cytokine kinetics of T. congolense infected wild type (WT, black symbol),
LysM-IL-10-/- (grey symbol) and TgAlbCre-IL10-/- (white symbol) mice. Dashed line represents cytokine levels in non-infected
animals. Data are represented as mean of 5 mice per group ± SEM and are representative of 2 independent experiments. (�:
p�0.05, ��: p�0.01, ���: p�0.005).
https://doi.org/10.1371/journal.ppat.1008170.g003
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increased serum AST (aspartate aminotransferase, reflecting systemic tissue injury) and ALT
(alanine aminotransferase, reflecting liver injury) levels as well as creatinine (reflecting kidney
injury) levels (Fig 5A–5C). In TgAlbCre-IL10-/- mice, this observation coincides with
increased serum levels of pro-inflammatory cytokines (IFN-γ, TNF, IL-12p70, IL-6 and MIF)
which were documented to contribute to T. congolense-induced tissue destruction (Fig 5D)
Fig 4. Hepatocyte-specific IL10-deficiency correlates with decreased B cell and patrolling monocyte numbers,
increased MHC-II expression on inflammatory monocytes and increased PMN numbers in the blood during the
later stage of T. congolense infection. Kinetic of (A) the percentage of CD45+ cells, (B) the number of white blood
cells (WBC, including B cells, T cells, patrolling monocytes, polymorphonuclear cells (PMN) and inflammatory
monocytes) and (C) the MHC-II expression levels on inflammatory monocytes expressed in delta median fluorescence
intensity (delta MFI) during the course of T. congolense infection in wild type (WT, black symbol), LysM-IL-10-/- (grey
symbol) and TgAlbCre-IL10-/- (white symbol) mice. The gating strategy is described in S3A Fig. Data are
represented ± SEM (5 mice per group) and are representative of 2 independent experiments. (�: p�0.05, ��: p�0.01,
���: p�0.005).
https://doi.org/10.1371/journal.ppat.1008170.g004
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[20,25–27]. In line with previous observations, LysM-IL-10-/- mice also showed higher sys-
temic levels of TNF compared to WT mice [15].
Collectively, we observed that parasites can induce IL-10 production by hepatocytes and
that hepatocyte-derived IL-10 is crucial to attenuate systemic inflammation and T. congolense
infection-associated pathogenicity during the later stages of infection resulting in a prolonged
survival.
Hepatocyte-specific IL10-deficiency correlates with increased
hepatosplenomegaly and an altered cellular tissue composition during T.
congolense infection
During chronic infections with trypanosomatids, including African trypanosomes, hepatosple-
nomegaly develops as an additional complication associated with the disease [20,22,23,28].
This pathological feature results in the overall increase in T. congolense infection-associated
mouse body weight (Fig 2C) [20,29]. Notably, though T. congolense infections induce hepatos-
plenomegaly in all mouse strains used in this study, this feature was most pronounced in
TgAlbCre-IL10-/- mice (Fig 6A and 6B) correlating with a higher mouse weight. However,
when subtracting the level of hepatosplenomegaly (i.e. the weight of liver and spleen) from the
actual mouse weight it appears that T. congolense infected animals, compared to non-infected
animals, loose weight (which is also observed in cattle [30]) (S4 Fig). In this context,
TgAlbCre-IL10-/- mice showed an earlier and significantly higher weight loss compared to the
other groups.
Remarkably, the number of liver-associated cells, comprising both hepatocytes (CD45-
cells) and liver-associated leukocytes (CD45+ cells), significantly increased in all infected ani-
mals compared to non-infected animals, with no further increase in TgAlbCre-IL10-/- mice
(Fig 6C) despite the significantly bigger liver size in these animals (Fig 6A and 6B). However,
livers from TgAlbCre-IL10-/- mice contained significantly lower numbers of hepatocytes but
tended to have higher numbers of leukocytes compared to WT and LysM-IL-10-/- mice. Also
the spleens of all infected mice contain more WBC compared to non-infected mice, but, simi-
lar to the liver, TgAlbCre-IL10-/- spleens do not contain more WBC than WT or LysM-IL-10-/-
spleens (Fig 6D). Conversely, spleens from infected TgAlbCre-IL10-/- mice encompass signifi-
cantly higher numbers of red blood cells (RBCs, Fig 6E, see gating strategy [20]) compared to
infected WT and LysM-IL-10-/- mice. Hence, the enhanced splenomegaly observed in
TgAlbCre-IL10-/- mice might be due to a higher level of extramedullary erythropoiesis, a phe-
nomenon which was reported before to cause splenomegaly in T. congolense infected animals
[20,29].
Collectively, the absence of hepatocyte-derived IL-10 results in a more pronounced hepa-
tosplenomegaly, which correlated with an altered tissue cellular composition.
Hepatocyte-specific IL10-deficiency correlates with enhanced
erythrophagocytosis, increased hemodilution and thrombocytopenia
during T. congolense infection
We have shown before that T. congolense infection causes hemodilution, due to the low yet
chronic nature of the inflammation, which coincides with the occurrence of hepatosplenome-
galy [20]. Interestingly, infected TgAlbCre-IL10-/- mice exhibited more severe hemodilution
compared to WT and LysM-IL-10-/- mice as illustrated by an enhanced blood (Fig 7A) and
plasma (Fig 7B) volume. This increased hemodilution resulted in thrombocytopenia, encom-
passing a decrease in platelet counts per blood volume and in the absolute platelet number in
the blood of the respective mice, which is again most pronounced in TgAlbCre-IL10-/- mice
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(Fig 7C and 7D). Conversely, the total number of RBCs in the blood of infected animals is unaf-
fected compared to naive animals (S5A Fig). Yet, the composition of RBCs (using the gating
strategy described in S3B Fig) is altered during infection (S5B Fig), with a decrease in the num-
ber of mature RBCs (suggesting enhanced erythrophagocytosis or impaired RBC maturation)
Fig 5. Hepatocyte-specific IL10-deficiency correlates with an increased tissue pathogenicity and increased serum
cytokine levels at day 45 post T. congolense infection. A 45 days p.i. (A) serum ALT, (B) AST and (C) creatinine
levels as well as (D) cytokine levels of IFN-γ, TNF, IL12p70, IL-6, MIF and IL-10 were determined via ELISA for wild
type (WT, black symbol), LysM-IL-10-/- (grey symbol) and TgAlbCre-IL10-/- (white symbol) mice. Dashed line
represents cytokine levels in non-infected animals. Data are representative of 3 independent experiments and
presented as mean of 3 individual mice per group ± SEM. (�: p�0.05, ��: p�0.01).
https://doi.org/10.1371/journal.ppat.1008170.g005
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Fig 6. Hepatocyte-specific IL10-deficiency correlates with increased hepato-splenomegaly and an altered tissue
cellular composition at day 45 post T. congolense infection. A) Liver and spleen weight of T. congolense infected wild
type (WT, black symbol), LysM-IL-10-/- (grey symbol) and TgAlbCre-IL10-/- (white symbol) mice (days 45 p.i.). (B)
Representative images of liver and spleen from naïve and T. congolense infected (day 45 p.i.) WT, LysM-IL-10-/- and
TgAlbCre-IL10-/- mice. (C) Total number of liver cells (including hepatocytes and leukocytes), hepatocytes and
leukocytes in WT (black symbol), LysM-IL-10-/- (grey symbol) and TgAlbCre-IL10-/- (white symbol) mice (days 45 p.
i.). (D and E) Total number of splenic white blood cells (WBCs) and red blood cells (RBCs) in WT (black symbol),
LysM-IL-10-/- (grey symbol) and TgAlbCre-IL10-/- (white symbol) mice (days 45 p.i.). Dashed line represents cytokine
levels in non-infected animals. Data are represented as mean of at least 3–5 mice per group ± SEM and are
representative of 2 independent experiments. (�: p�0.05, ���: p�0.005).
https://doi.org/10.1371/journal.ppat.1008170.g006
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and an increase in the number of immature RBCs (reflecting enhanced extramedullary erythro-
poiesis). However, no differences were observed between TgAlbCre-IL10-/-, LysM-IL-10-/- and
WT mice in this respect. Enhanced extramedullary erythropoiesis is corroborated by the signifi-
cantly increased numbers of RBCs in the spleen of infected animals (Fig 6E), encompassing
more mature RBCs in TgAlbCre-IL10-/- mice compared to the other groups (S5B Fig). These
data argue against an impaired RBC maturation in infected mice, and indeed, all RBC matura-
tion stadia (using the gating strategy described in S3B Fig) are similar between WT and
TgAlbCre-IL10-/- mice (S6 Fig).
In addition, using an in vivo erythrophagocytosis assay [31], we observed that TgAlbCre-
IL10-/- mice exhibited an enhanced erythrophagocytosis both at the level of the spleen and
liver compared to WT mice (Fig 8). Hence, the combination of enhanced extramedullary
erythropoiesis (resulting in more splenomegaly) and enhanced erythrophagocytosis in
TgAlbCre-IL10-/- mice might explain the comparable total numbers of RBC in the blood as
compared to the other groups.
Collectively, these results indicate that hepatocyte-derived IL-10 plays an important role in
attenuating erythrophagocytosis, hemodilution as well as thrombocytopenia.
Hepatocyte-specific IL10-deficiency correlates with an increased hepatic
pro-inflammatory phenotype during T. congolense infection
To gain further mechanistic insight in the phenotype of T. congolense-infected TgAlbCre-
IL10-/- mice, we zoomed in on the liver, since the effects of this deficiency are expected to be
most apparent within that organ. In first instance, we investigated the local cytokine produc-
tion by hepatocytes and hepatic leukocytes to assess whether the systemic increase in pro-
inflammatory cytokines (Figs 3 and 5D) could be phenocopied at the tissue level in these mice.
Quantitative gene expression analysis of the hepatocyte fraction from T. congolense infected
TgAlbCre-IL10-/- mice demonstrated a strongly increased expression of the prototype inflam-
matory cytokines Il6 and Mif (but not Tnf), the inflammatory chemokine Cxcl10, and the
inflammatory enzyme Nos2 (but not Arg1) compared to hepatocytes from WT and LysM-IL-
10-/- mice, suggesting an overall more prominent pro-inflammatory profile (Fig 9A). Interest-
ingly, this inflammatory profile is only partially recapitulated in the hepatic CD45+ leukocyte
compartment of infected TgAlbCre-IL10-/- mice, with a clear upregulation of Nos2, Cxcl10,
and to a lesser extent Tnf, but not Il6 and Mif (Fig 9B). Moreover, Arg1 is higher expressed in
these cells from TgAlbCre-IL10-/- mice as compared to WT and LysM-IL-10-/- mice, although
the Arg1 mRNA levels remain below those seen in naive animals. Interestingly, CXCL10 is also
known as a hepatocyte apoptosis-promoting chemokine [32,33], an important chemokine pro-
moting hepatic inflammation in chronic or acute liver injury through recruitment of leuko-
cytes to the liver parenchyma [34–36]. Hence, its enhanced expression in both hepatocyte- and
leukocyte fractions from infected TgAlbCre-IL10-/- mice, in association with the lower expres-
sion levels of the hepatocyte renewing factor telomerase reverse transcriptase (Tert1) in hepa-
tocytes [37] (Fig 9A, lower panels), may collectively explain the lower numbers of hepatocytes
in TgAlbCre-IL10-/- mice.
At the protein level, hepatocytes from TgAlbCre-IL10-/- mice exhibited a significantly
increased secretion of IL-6, MIF and nitric oxide (NO; indicative of Nos2 enzyme activity) as
compared to hepatocytes from infected WT and LysM-IL-10-/- mice, corroborating the mRNA
data (Fig 10, upper panels). Hepatic leukocytes from TgAlbCre-IL10-/- mice produced the
highest levels of NO and IFN-γ (Fig 10, lower panels), while the levels of IL-6, TNF and MIF
were increased upon infection but not different between the groups.
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Collectively, by comparing WT, LysM-IL-10-/- and TgAlbCre-IL10-/- mice, hepatocyte-
derived IL-10 was found to be crucial to dampen the pro-inflammatory immune response at
the level of the liver, decreasing the inflammatory profile of both hepatocytes and leukocytes in
this organ. Hereby, hepatocytes from TgAlbCre-IL10-/- mice have besides a more pro-inflam-
matory gene/protein expression profile also an increased Cxcl10 and decreased Tert1 expres-
sion, which in turn may negatively affect hepatocyte survival.
Hepatocyte-specific IL10-deficient mice have an enhanced iron-
homeostasis gene expression profile during T. congolense infection
During chronic inflammation, iron homeostasis is modulated, whereby excess iron can cause
hepatocellular damage through the production of harmful reactive oxygen species (ROS) [38].
Hence, also genes involved in iron-regulation and -homeostasis were investigated in both the
hepatocyte and hepatic leukocyte fraction and were found to be modulated during T. congo-
lense infection (Fig 11). At the level of the hepatocytes (Fig 11, upper panels), these genes were
Fig 7. Hepatocyte-specific IL10-deficiency correlates with increased hemodilution and thrombocytopenia at day
45 post T. congolense infection. Both non-infected and T. congolense infected (45 days p.i.) mice were exsanguinated
via cardiac puncture and tested for (A) total blood volume and (B) total packed cell volume (PCV, black bar) and total
plasma (white bar) volume which were calculated based on the total blood (A) volume and the % PCV. (C) The
concentration of CD41+ platelets (gated as described in [20]) and (D) total number of platelets in the total blood
volume was determined was determined for both non-infected and infected animals. WT (black symbol), LysM-IL-
10-/- (grey symbol) and TgAlbCre-IL10-/- (white symbol) mice. Data are represented as mean of at least 3–5 mice per
group ± SEM and are representative of 2 independent experiments. (�: p�0.05, ��: p�0.01, ����: p�0.001).
https://doi.org/10.1371/journal.ppat.1008170.g007
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skewed towards an increased iron uptake (i.e. higher Hmox-1, Nramp2) and retention (i.e.
higher Fhc, Lcn-2) in TgAlbCre-IL10-/- mice. Accordingly, the gene expression profile of iron
regulating genes in liver leukocytes is also suggestive of an amplified iron uptake (i.e. higher
Hmox-1, Lcn-2) and iron processing (i.e. higher Fpn-1, Fhc) in TgAlbCre-IL10-/- mice com-
pared to the other two groups (Fig 11, lower panels).
Collectively, the hepatocyte and hepatic leukocyte iron-homeostasis gene analysis of
TgAlbCre-IL10-/- mice are suggestive of an enhanced iron uptake and retention, which in turn
may favour hepatic damage.
Anti-MIF Nb treatment attenuates effects of Hepatocyte-specific
IL10-deficiency during T. congolense infection
Finally, we wished to ascertain whether the increased inflammatory cytokine production is
responsible for the increased pathogenicity of T. congolense infection in TgAlbCre-IL10-/-
mice. In this respect, we have reported before that MIF plays a key role in T. congolense infec-
tion associated pathogenicity [39] and we demonstrated here that MIF levels were significantly
upregulated in TgAlbCre-IL10-/- mice during later stages of infection both systemically and in
Fig 8. Hepatocyte-IL10 deficiency enhances erythrophagocytosis during T. congolense infection. At 40 days p.i., 109
pHrodo labelled RBCs isolated from non-infected WT mice were injected i.v. in WT (black bar) or TgAlCre-IL10-/-
(open bar) mice. 18 h later, mice were sacrificed and liver (A) and spleen (B) myeloid phagocytic cells (MPC), namely
CD11b+Ly6CintLy6G+ PMNs, CD11b+Ly6ChighLy6G- monocytes and CD11b+Ly6C-Ly6G-F4/80+ macrophages
(identified as described in [20]) were tested for delta median fluorescence intensity (MFI) of the intracellular pHrodo
signal determined by subtracting the PE signal of cells from mice receiving unlabeled RBCs from the PE signal of cells
from mice receiving pHrodo-labeled RBCs. Results are representative of 2 independent experiments and presented as
mean of 3 individual mice ± SEM. �: p�0.05, ��: p�0.01.
https://doi.org/10.1371/journal.ppat.1008170.g008
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the liver (Figs 3 and 10A). Moreover, in contrast to IL-6, MIF is an upstream regulator of the
inflammatory cascade whose blockade may be more efficient at attenuating the inflammatory
immune response [40]. Hence, we evaluated whether neutralization of MIF, using a half-life
extended anti-MIF Nb [39], could attenuate the pathology observed in TgAlbCre-IL10-/- mice.
To this end, TgAlbCre-IL10-/- mice were treated starting from day 30 p.i. (i.e. a time point
Fig 9. Gene expression profiles of pro- and anti-inflammatory cytokines/mediators as well as chemokines and
Tert-1 in hepatocytes and liver-associated leukocytes from T. congolense infected animals. Gene expression levels of
pro-inflammatory and anti-inflammatory cytokines/mediators as well as chemokines in hepatocytes (A, upper panel)
and liver leukocytes (B, lower panels) fraction of T. congolense infected (day 45 p.i.) WT (black symbol), LysM-IL-10-/-
(grey symbol) and TgAlbCre-IL10-/- (white symbol) mice. Results are presented as fold change whereby the expression
levels were normalized using S12 and expressed relatively to the expression levels in the corresponding non-infected
animals. Gene expression levels of Tert1 in the hepatocyte fraction of WT (black symbol), LysM-IL-10-/- (grey symbol)
and TgAlbCre-IL10-/- (white symbol) mice. Data are represented as mean of at least 3–5 mice per group ± SEM and are
representative of 2 independent experiments. (�: p�0.05, ��: p�0.01, ���: p�0.005).
https://doi.org/10.1371/journal.ppat.1008170.g009
Hepatocyte-IL-10 attenuates African trypanosomiasis-associated pathogenicity
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1008170 February 3, 2020 14 / 29
when anemia difference between the groups became apparent, see Fig 3D) with 250 μg of a
half-life extended anti-MIF Nb for ~3 weeks (twice per week) and infection parameters (ane-
mia and parasitemia) were monitored. The anti-MIF Nb treatment did not affect parasitemia
development in TgAlbCre-IL10-/- mice (Fig 12A, upper panel), but it clearly prevented anemia
from further progressing (Fig 12A, lower panel). Since inflammatory cytokines play a key role
in anemia development and since MIF can be an initiator of inflammatory cytokine produc-
tion, we also evaluated the systemic levels of various pro-inflammatory cytokines. Interest-
ingly, treatment of TgAlbCre-IL10-/- mice with an anti-MIF Nb resulted in a significant
reduction in systemic TNF, IL-6 and MIF levels and this to levels comparable to those
observed in WT mice (Fig 12B).
Collectively, blocking MIF in TgAlbCre-IL10-/- mice, using an anti-MIF Nb, was found to
attenuate anemia and excessive systemic inflammatory cytokine levels, without affecting para-
site burden.
Discussion
Trypanosomatids are very proficient in evading the host’s immune response, yet, these escape
mechanisms are associated with a chronic inflammatory state that culminates into increased tis-
sue damage and finally into host death [41]. IL-10 was shown to be essential to attenuate the
inflammatory response and prevent early death of the host due to a hyper-inflammation syn-
drome [19]. Hence, a well-timed balance between the levels of pro-inflammatory cytokines
(required for initial parasite control) and anti-inflammatory cytokines (required to dampen
Fig 10. Cytokine profile of liver cell cultures following T. congolense infection. At day 45 post T. congolense infection, fractionated
liver cells (hepatocytes and leukocytes) were isolated and cultured for 36 hours and subsequently tested in ELISA for cytokine levels of
IFN-γ, TNF, IL-6 and MIF as well as NO. Cytokine protein levels of hepatocytes (A, upper panels) and liver leukocytes (B, lower panels).
WT (black symbol), LysM-IL-10-/- (grey symbol) and TgAlbCre-IL10-/- (white symbol) mice. Dashed line represents cytokine levels in
non-infected animals. Non-infected animals did not show any detectable cytokine levels. Data are represented as mean of at least 3–5
mice per group ± SEM and are representative of 2 independent experiments. (�: p�0.05, ��: p�0.01, ���: p�0.005).
https://doi.org/10.1371/journal.ppat.1008170.g010
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excessive pro-inflammatory effects) is essential to prevent excessive tissue damage. Previous
research has shown that leukocytes (i.e. Tregs. alternatively activate macrophages and Ly6C-
patrolling monocytes) can constitute a source of IL-10 required to dampen some specific
aspects of immunopathology (e.g. liver injury) during the early stages of infection [14,15,19,24].
Using hepatocyte-specific IL-10 deficient (TgAlbCre-IL10-/-) mice and IL-10-eGFP reporter
mice we now show for the first time that hepatocytes from T. congolense infected mice can also
produce IL-10 (see Fig 1C). Moreover, we provide evidence that parasite-derived components,
can trigger IL-10 production by hepatocytes from non-infected animals, indicating that they
can sense and respond to the presence of trypanosomes. In this context, in another parasitic
model, it was recently shown that hepatocytes can respond to Leishmania infantum infection by
the activation of inflammatory mechanisms and the production of IL-10 in order to balance the
inflammatory response and avoid cell damage [42].
The potential of hepatocytes to produce IL-10 was found to be crucial to control immuno-
pathology during the chronic stage of T. congolense infection. Indeed, although TgAlbCre-
IL10-/- mice behaved similar to WT and LysMCre-IL-10-/- mice during the early stages of
infection, they succumbed much earlier to the infection coinciding with increased tissue path-
ogenicity. This was evidenced by the increased ALT (suggesting liver injury), AST (suggesting
systemic injury) and creatinine (suggesting kidney failure) levels, as well as by a more severe
chronic anemia. The enhanced pathogenicity correlated with a significant systemic increase in
all pro-inflammatory cytokines documented to play a pathogenic role during T. congolense
infection [20,27,43]. In addition, at later stages of infection, the numbers of PMN as well as the
expression of MHC-II on Ly6C+ inflammatory monocytes, both documented to contribute to
tissue injury [22,26], were found to be significantly increased in the blood of TgAlbCre-IL10-/-
mice compared to the other groups, further strengthening the notion that these mice were in a
higher inflammatory state. In contrast, the numbers of Ly6C- patrolling monocytes,
Fig 11. Iron-homeostasis associated gene expression profiles of hepatocytes and liver-associated leukocytes from T. congolense
infected animals. Gene expression levels of iron-homeostasis associated genes in hepatocytes (A, upper panels) and the liver associated
leukocyte (B, lower panels) fraction of WT (black symbol), LysM-IL-10-/- (grey symbol) and TgAlbCre-IL10-/- (white symbol) mice.
Results are presented as fold change whereby the expression levels were normalized using S12 and expressed relatively to the expression
levels in the corresponding non-infected animals. Data are represented as mean of at least 3–5 mice per group ± SEM and are
representative of 2 independent experiments. (�: p�0.05, ��: p�0.01, ���: p�0.005).
https://doi.org/10.1371/journal.ppat.1008170.g011
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documented to be important to attenuate tissue damage caused by an extensive Ly6C+ mono-
cyte-associated inflammatory immune response [24], were found to be significantly reduced
in TgAlbCre-IL10-/- mice compared to WT and LysM-IL-10-/- mice. Furthermore, the number
of circulating B cells was found to be similar in both groups of mice and was only significantly
reduced in TgAlbCre-IL10-/- mice at later stages of infection. Since antibodies are required to
keep the parasitemia in check [11,44], the reduced B cell presence in the blood could in turn
explain the higher parasitemia levels observed in TgAlbCre-IL10-/- mice at later stages of infec-
tion. It is however important to realize that B cell counts in the blood do not reveal whether B
cell activation, the formation of plasma cells and antibody secretion, the induction of germinal
center reactions, or the activation of CD4+ T follicular helper cell numbers and function,
which are known to restrict T. congolense parasitemia [11,44], are impaired. However, this is
highly likely since trypanosomes cause a general B cell depletion pathology, which is initiated
by the very rapid disappearance of immature B cells in the bone marrow, as well as transitional
and IgM+ marginal zone B cells from the spleen, followed by a gradual depletion of Follicular
B cells (FoB) [45,46]. Though the cause of B cell depletion is currently unknown, it was shown
that the kinetics of this B cell loss and parasite outgrowth depends on different factors such as
parasite virulence and the level of inflammation [45,46]. Therefore, the observed reduced B
cell numbers in TgAlbCre-IL10-/- mice at the later phase of infection is most likely due to a
higher/persistent inflammatory immune response [45,47]. In turn, this higher and persistent
inflammatory immune response can also contribute to multiple organ failure and host death
[19,23]. Hence, during the chronic stage of the infection, hepatocyte-derived IL-10 seems to be
more crucial to dampen the inflammatory immune response than leukocyte-derived IL-10. A
more in-depth analysis of the liver at this stage of infection revealed that TgAlbCre-IL10-/-
mice had less hepatocytes, but the remaining hepatocytes showed a strongly increased pro-
inflammatory gene expression and protein secretion as compared to WT or LysMCre-IL10-/-
mice. Moreover, the protein and gene expression levels of IL-6 and Mif, two cytokines docu-
mented to play a key role in T. congolense-associated pathology (i.e. susceptibility versus toler-
ance) and liver injury in particular [20,48–50], were drastically increased in hepatocytes from
TgAlbCre-IL10-/- mice compared to the other groups. Interestingly, we have shown before
that MIF is a key player in T. congolense-associated pathogenicity [20]. Indeed, absence of the
pro-inflammatory regulator MIF, using Mif-deficient mice, was shown to attenuate the inflam-
matory immune response during the chronic stage of infection resulting in a reduced infec-
tion-associated pathogenicity (i.e. anemia, liver and tissue injury) and prolonged survival by
promoting IL-10 production [20,22]. Notably, hepatocyte-derived MIF was also shown in
another model (i.e. alcoholic liver disease) to be a driving force for liver injury [50]. Overall, an
interesting picture emerges whereby hepatocytes are a source of two cytokines that counterbal-
ance each other and exert opposing effects during chronic T. congolense infection: MIF attenu-
ates IL-10 production and promotes pathogenicity; while IL-10 keeps the MIF production in
check and softens pathogenicity. Hence, therapeutic approaches that tilt the balance of “hepa-
tocyte” cytokine production in favour of IL-10 are likely to majorly impact the wellbeing and
survival of T. congolense-infected animals. Given that, in contrast to IL-6, MIF is an upstream
regulator of the inflammatory cascade whose blockade may be more efficient at attenuating
the inflammatory immune response [40]. This notion was strengthened by the fact that inter-
fering with MIF signaling using a Nb-based approach indeed attenuates the excessive inflam-
matory immune response as well as the most prominent pathological feature associated with
T. congolense infections, i.e. anemia, in TgAlbCre-IL10-/- mice.
Our results further strengthen the notion that during the course of T. congolense infection,
a sequential transition occurs in the cells that produce IL-10. During the early stages, leuko-
cytes seem to play a decisive role as IL-10 producing cells, yet during the later stage hepatocytes
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become important IL-10 producing cells in an attempt to counteract the host’s inflammatory
response. As a matter of fact, at this later stage of T. congolense infection, hepatocyte-derived
IL-10 plays a decisive role to dampen excessive tissue damage and immunopathology. More-
over, hepatocytes from WT infected mice, but not TgAlbCre-IL10-/- infected mice, exhibited
an increased IL-10R gene expression, suggesting that autocrine/paracrine IL-10R signalling on
hepatocytes may be required to allow efficient control over inflammation. Additional
Fig 12. Half-life extended anti-MIF Nb treatment attenuates anemia and pro-inflammatory cytokine levels in
Hepatocyte-IL10 deficient mice during T. congolense infection. At 30 days p.i., TgAlbCre-IL10-/- mice (4–5 mice/
group) were treated i.p. with 250 μg half-life extended anti-MIF Nbs (grey bars) or left untreated (white bars) for 3
weeks (twice a week). Wild type mice (black bars) were left untreated and included as negative controls. A. Parasitemia
(upper panel) and anemia (lower panel) progression expressed in percentage relative to levels recorded prior to
initiating the treatment were monitored for 3 weeks. B. Serum cytokine levels recorded 3 weeks post treatment. Data
are represented as mean of at least 4–5 mice per group ± SEM. (�: p�0.05, ��: p�0.01, ���: p�0.005).
https://doi.org/10.1371/journal.ppat.1008170.g012
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experimentation will be required to prove this point. One of the important features that is reg-
ulated by hepatocyte-derived IL-10 is the expression of iron homeostasis-associated genes, sug-
gesting an enhanced liver iron-uptake/retention in TgAlbCre-IL10-/- mice. Indeed, TgAlbCre-
IL10-/- mice exhibited an increased expression of Hmox-1 (indicating enhanced iron uptake)
as well as Fpn-1 (indicating enhanced iron export) and Fhc (indicating enhanced iron reten-
tion). These modulations in iron-homeostasis regulating genes are suggestive for an enhanced
erythrophagocytosis and a reduced iron availability for erythropoiesis [51], which was also
reflected by the lower number of mature RBCs in the blood (S5A Fig). In this context, we con-
firmed that TgAlbCre-IL10-/- mice exhibited an enhanced erythrophagocytosis, yet, the eryth-
ropoiesis efficiency was not affected. This strengthens the notion that iron is retained into liver
cells in the absence of hepatocyte IL-10, which may then further fuel oxidative stress and liver
injury [52]. Moreover, the increased hepatosplenomegaly in TgAlbCre-IL10-/- mice leads to
hemodilution, which in combination with a reduced erythropoiesis aggravates one of the most
prominent immunopathological features of T. congolense-infected animals: anemia. In this
context, MIF might again be an important player as it was shown previously to be a driving
force in suppressing erythropoiesis and promoting hemodilution leading to the observed
“apparent” anemia during T. congolense infection [20].
Overall, the crucial role of hepatocytes at the chronic stage of infection might be linked to
their inherent ability to contribute to liver regeneration [37]. Given that hepatocytes play a key
role in liver homeostasis, identification of target molecules or pathways that are modulated
between trypano-susceptible and -tolerant animals might open perspectives to develop a more
specific approach to alleviate infection-associated pathogenicity and allow a restoration of nor-
mal organ functions. Since MIF was shown to be a key player in trypanosomosis-associated
pathogenicity and found to be strongly induced in hepatocytes from TgAlbCre-IL10-/- mice
compared to the other groups, and interfering with MIF signaling using a Nb-based approach
attenuates the excessive inflammatory immune response as well as the most prominent patho-
logical feature associated with T. congolense infections, i.e. anemia, in TgAlbCre-IL10-/- mice,
this could be a prime candidate for further studies in this model. Therefore, using MIF block-
ing Nbs at later stages of infection might be a novel way to attenuate T. congolense associated
pathology and allow animals to remain productive.
Materials and methods
Ethics statement
All experiments, maintenance and care of the mice complied with the European Convention
for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes
guidelines (CETS n˚ 123) and were approved by the Ethical Committee for Animal Experi-
ments (ECAE) at the Vrije Universiteit Brussel (Permit Numbers: 14-220-05 and 14-220-06).
Parasites, mice and infections
Eight to twelve weeks old female C57BL/6 mice were purchased from Janvier, France. IL-10-/-
(B6.129P2-Il10tm1Cgn/J), AlbCre (B6.Cg-Tg(Alb-cre)21Mgn/J, JAX stock #003574), LysMCre
(B6.129P2-Lyz2tm1(cre)Ifo/J, JAX stock #004781) and Vert-X (B6(Cg)-Il10tm1.1Karp/J) were pur-
chased from Jackson Laboratory, USA. LyzMCre/+ IL-10fl/fl (i.e. LysM-IL10) and AlbCre/+ IL-
10fl/fl (i.e. TgAlbCre-IL10) mice were generated in house by crossing the LysMCre and AlbCre
mice with IL-10fl/fl mice (a kind gift of W. Muller, University of Manchester, Manchester,
United Kingdom), respectively. The genotyping profile of the LysM-IL10-/- and TgAlbCre-
IL10-/- mice is included (S7 Fig).
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Clonal T. congolense parasites (Tc13) were kindly provided by Dr. Henry Tabel (University
of Saskatchewan, Saskatoon) and stored at -80˚C. Female mice (7–8 weeks old) were infected
intraperitoneally (i.p.) with 2 x 103 Tc13 trypanosomes. Parasite and red blood cell (RBC)
numbers in blood were determined via hemocytometer by tail-cut (2.5 μl blood in 500 μl
RPMI). Anemia was expressed as the percentage of reduction in RBC counts compared to
non-infected animals. Packed cell volume (PCV) was measured following collection of anti-
coagulated blood in heparinized capillaries and centrifugation at 9500×g for 7 min. using a
micro-centrifuge (Fisher BioBlock Scientific). Also the weight of the mice was followed during
the course of infection and the percentage weight change compared to non-infected animals at
the corresponding time.
Treatment experiments consisted of injecting TgAlbCre-IL10-/- mice (4–5 mice/group) i.p.
at day 30 post infection (p.i.) with 250 μg (in 200 μl PBS) of a half-life extended anti-MIF Nb
[39] and this for 3 weeks (twice a week). At regular time points blood was collected for parasi-
temia and RBC analysis and when the untreated TgAlbCre-IL10-/- mice started dying blood
was collected for cytokine analysis. Of note, anemia levels at day 30 p.i. of each individual
mouse were used to normalize the progression of anemia.
Serum and cell isolation
Blood from non-infected control and infected mice was harvested via tail-cut using heparin-
ized capillaries and centrifuged at 8000×g for 15 min. Serum was harvested and stored at
-20˚C. Hepatocytes and liver leukocytes from infected and non-infected mice were purified as
described in [53]. Briefly, liver cells were obtained by perfusing the liver with 10 ml of cold
PBS via the inferior vena cava, mechanical disruption of the liver, followed by passing cell sus-
pensions over a 70 μm nylon mesh filter and a 33% Percoll gradient separation, after which
cells were resuspended in complete medium (RPMI supplemented with 5% FCS, 2mM L-glu-
tamine, 100 U/ml penicillin and 100 μg/ml streptomycin (all from Invitrogen Life Technolo-
gies)). Next, the fractionated cell suspension was centrifuged (7 min., 300×g, 4˚C) and the
pellet treated with erythrocyte-lysis buffer. Following centrifugation (7 min., 300×g, 4˚C) the
pellet was resuspended in 2–5 ml complete medium, cells counted and adjusted at 107 cells/ml
for flow-cytometric analysis, cell culturing and RT-PCR analysis. Of note, the 33% Percoll gra-
dient yielded hepatocytes (in the upper layer) with at least 95% purity (see Fig 1A and 1B).
Spleen cells from infected and non-infected mice were obtained by homogenizing (dis-
rupted mechanically) the organs in 10 ml RPMI/5%FCS medium, passing the suspension
through a 70 μm nylon mesh filter and centrifugation (7 min., 300×g, 4˚C). Cells were counted
and brought at 107 cells/ml in RPMI/5% FCS medium for RBC analysis via flow cytometry.
Remaining cells were pelleted (7 min., 300×g, 4˚C) and subsequently treated with RBC lysis
buffer (0.15 M NH4Cl, 1.0 mM KHCO3, 0.1 mM Na2-EDTA) and processed as described for
the liver (see above) for analysis of white blood cells (WBCs).
Flow cytometry
To analyze the RBC composition, the blood and spleen cells were analysed omitting RBC lysis.
Briefly, total blood (2.5 μl diluted in 500 μl RPMI/5% FCS) and 106 spleen cells (in 100 μl) were
incubated (15 min., 4˚C) with Fc-gamma blocking antibody (anti-CD16/32, clone 2.4G2, BD
Biosciences), and subsequently stained with labelled antibodies (summarized in S1 Table) or
matching control antibodies. Samples were washed with FACS medium (5% FCS in HBS),
measured on FACSCanto II flow cytometer (BD Bioscience) and data were analysed using
FlowJo software (Tree Star Inc., Ashland, OR) by excluding CD45+ cells and gating on Ter-
119+ cells. After RBC lysis, the remaining cells (106 cells/100 μl) within the spleen (comprising
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leukocytes, WBCs) and liver (comprising leukocytes and hepatocytes) were analyzed as
described above. The results were analysed after exclusion of aggregated and death cells
(7AAD+, BD Pharmingen) and selection of CD45+ cells (leukocytes) and CD45- cells (hepato-
cytes). The total number of cells in each population was determined by multiplying the per-
centages of subsets within a series of marker negative or positive gates by the total cell number
determined for each tissue.
Erythrophagocytosis assay
The pHrodo-labelling of red blood cells (RBCs) was described in [31]. 109 pHrodo-labelled
RBCs isolated from non-infected wild type (WT) mice were injected i.v. in WT or TgAlbCre-
IL-10-/- mice. 18 h later, mice were sacrificed, and liver and spleen cells isolated as described
above. Next, via FACS (see S1 Table), liver and spleen CD11b+Ly6CintLy6G+ PMNs,
CD11b+Ly6ChighLy6G- monocytes and CD11b+Ly6C-Ly6G-F4/80+ macrophages were tested
for delta median fluorescent intensity (MFI) of the intracellular pHrodo signal determined by
subtracting the PE signal of cells from mice receiving unlabelled RBCs from the PE signal of
cells from mice receiving pHrodo-labelled RBCs.
In vitro cultures
Liver leukocytes and splenic cell populations isolated from infected and non-infected mice
were diluted in complete medium (RPMI-1640 medium, 5% FBS, 1% sodium pyruvate
(Gibco), 1% non-essential amino acids (Gibco), 1% glutamate, 1% penicillin-streptomycin),
plated in 48-well plates (Nunc) at 2.106 cells per ml and incubated at 37˚C in a 5% CO2 incuba-
tor for 36–48 h before supernatant was recovered and stored at -20˚C for further analysis. The
isolated hepatocytes were cultured in DMEM (Thermo-Scientific), supplemented with 5% FBS
and 100 mg ml-1 penicillin/streptomycin, at 2.106 cells per ml and incubated at 37˚C in a 5%
CO2 incubator for 36–48 h before supernatant was recovered and stored at -20˚C for further
analysis.
For the in vitro co-cultures of hepatocytes and liver leukocytes with parasites or parasite
lysate or parasite derived sVSG, parasites were isolated as described in [54,55]. Briefly, mice
with a systemic T. congolense (Tc13) parasitemia were exsanguinated and parasites were puri-
fied from heparinized blood by DEAE-cellulose (DE-52, Whatman) chromatography and
sVSG was isolated via ion-exchange chromatography and gel filtration. Lysate was prepared by
3 repetitive freeze thawing cycles (-80˚C, 37˚C). The concentration of both sVSG and lysate
was determined spectrophotometrically (Nanodrop) following Prosep-Remtox (Immuno-
source, Schilde, Belgium) treatment and samples confirmed to be LPS free by using the Limu-
lus Amebocyte Lysate Kinetic-QCL Kit (Cambrex, East Rutherford, NJ, USA) in accordance
with the manufacturer’s instructions. Both sVSG and lysate were either used immediately or
stored at −20˚C. Finally, 2.106 liver cells per ml were incubated at 37˚C in a 5% CO2 incubator
with 107 parasites or 50 μg lysate or 5 μg sVSG or left untreated (negative control) for 36 hours
after which the culture supernatant was collected and stored at -80˚C for further cytokine
ELISA analysis.
Quantification of cytokines
All serum cytokines except MIF were quantified using the V-PLEX Custom Mouse Cytokine
kit (catalogue number K152A0H) from Meso Scale Discovery (Rockville, MD, USA) according
to the manufacturer’s protocol. The MIF protein was quantified using a kit from R&D Systems
according to the manufacturers description. Alternatively, culture medium concentrations of
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MIF, TNF, IFN-γ and IL-10 (R&D Systems) as well as IL-6 (Pharmingen) were determined by
ELISA as recommended by the suppliers.
Real-time quantitative polymerase chain reaction (RT-QPCR) analysis
One μg of total RNA prepared from 107 cells (RNeasy plus mini kit, Qiagen) was reverse tran-
scribed using oligo(dT) and Superscript II Reverse Transcription following the manufacturer’s
recommendations (Roche Molecular Systems). RT-QPCR was performed in an iCycler iQ,
with iQ SYBR Green Supermix (Bio-Rad) as described in [56]. Primer sequences are listed in
S2 Table. PCR cycles consisted of 1-minute denaturation at 94˚C, 45-second annealing at
55˚C, and 1-minute extension at 72˚C. Fold change in gene expression was expressed as com-
pared to non-infected animals after normalization against the Ct value of the ribosomal S12
(Mrps12) protein as household gene.
Aspartate transaminase (AST), alanine transaminase (ALT) and creatinine
measurement
Serum AST and ALT levels were determined as described by the suppliers (Boehringer Mann-
heim Diagnostics). Serum creatinine levels were determined as described by the suppliers
(Abcam).
Statistics
The GraphPad Prism 7 software was used for statistical analyses. For samples that complied
with the D’Agostino-Pearson test, a student t-test for paired analyses or one-way ANOVA
with multiple comparisons was performed and a Log-rank (Mantel-Cox) test was used for sur-
vival. Alternatively, a non-parametric Mann-Whitney (two groups) and Kruskal-Wallis (three
or more groups) was performed for experiments that did not comply with the D’Agostino-
Pearson test. Values are expressed as mean ± SEM. Values of p�0.05 are considered statisti-
cally significant, where � = p� 0.05, �� = p� 0.01 and ��� = p� 0.001.
Supporting information
S1 Table. Fluorescently labeled antibodies used.
(DOCX)
S2 Table. Primer used for RT-PCR analysis.
(DOCX)
S1 Fig. Leukocytes are proficient IL-10 producing cells during the chronic phase of T. congo-
lense infection. Representative FACS profile of purified leukocytes at day 45 post T. congolense
infection. The gating strategy used to discriminate between leukocytes and potential contaminating
hepatocytes/debris is based on an FSC-A versus SSC-A (A) and a CD45 versus FSC-A (B) plot,
whereby leukocytes were selected based on their CD45+ profile. (C) Histogram plot showing the
intensity of the IL-10-eGFP signal in leukocytes from IL-10-eGFP reporter (blue) mice and, as neg-
ative control, in leukocytes from TgAlbCre-IL10-/- (red) mice. At day 45 post T. congolense infec-
tion, isolated hepatocytes from WT (black symbol) and TgAlbCre-IL10-/- (white symbol) mice
were cultured for 36 hours and subsequently tested in ELISA for IL-10 protein levels (D) or tested
in RT-PCR for IL-10 and IL-10R gene expression (E and F, respectively). Of note, RT-PCR results
are presented as fold change whereby the expression levels were normalized using S12 and
expressed relatively to the expression levels in the corresponding non-infected animals. Non-
infected animals did not show any detectable IL-10 protein levels (Dashed line). Data are
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represented as mean of at least 3–5 mice per group ± SEM and are representative of 2 independent
experiments. (�: p�0.05, ��: p�0.01, ���: p�0.005). ND: Not detected.
(TIF)
S2 Fig. Hepatocyte-specific IL10-deficiency does not affect survival and tissue pathogenic-
ity during T. brucei infection. A) Parasitemia, (B) Survival, (C) weight change, (D) anemia of
T. brucei infected wild type (WT, black symbol) and TgAlbCre-IL10-/- (red symbol) mice.
Data are represented as mean (A, C-G) or median (B) of 3–5 mice per group ± SEM and are
representative of 2–3 independent experiments.
(TIF)
S3 Fig. Gating strategy used to identify different leukocytes and red blood cells (RBCs) within
the blood during T. congolense infection. Representative FACS profiles on blood of T. congolense
infected animals to identify different leukocyte (A) and RBC (B) subsets. For the leukocyte, first, a
CD45 versus FSC-A plot allows identifying CD45+ cells, after which these cells put in a CD11b ver-
sus FSC plot to identify CD11b+ cells and CD11b- cells (lymphocytes). The CD11b- cells (lympho-
cytes) were then plot in a CD19 versus MHC-II plot to identify B cells (CD19+MHC-II+) and T
cells (CD19-MHC-II-). The CD11b+ cells were plotted in a Ly6C versus Ly6G plot to identify
inflammatory monocytes (Ly6C+Ly6G-) and PMN (Ly6CintLy6G+). Alternatively, the CD11b+
cells were plotted in an Ly6C versus MHC-II plot to identify patrolling monocytes (Ly6C-MH-
C-II-). Regarding the RBC subsets, a Ter119 versus FSC-A plot allows identification of RBCs (i.e.
Ter-119+ cells). These cells be plot in a CD71 versus Ter-119 plot to identify immature
(Ter119+CD71+) and mature (Ter119+CD71-) cells, or in a CD44 versus FSC-A plot to identify
nucleated erythroblasts (pro- and basophilic (I), polychromatic (II), orthochromatic (III) erythro-
blasts) from nucleated reticulocytes (IV) and enucleated erythrocytes (V).
(TIF)
S4 Fig. Absolute weight loss of T. congolense infected mice. Absolute weights of T. congolense
infected wild type (WT, black symbol) and TgAlbCre-IL10-/- (red symbol) mice, when consid-
ering (subtracting) the increase in hepatosplenomegaly. Data are represented as mean of 3–5
mice per group ± SEM and are representative of 2–3 independent experiments.
(TIF)
S5 Fig. During the chronic phase of T. congolense infection the RBC composition of the
blood and spleen is changed. (A) Total number of RBCs as well as mature and immature RBCs
in the blood of T. congolense infected (Day 45 p.i.) mice, which were calculated based on the
total blood volume (Fig 6A). WT (black symbol), LysM-IL-10-/- (grey symbol) and TgAlbCre-
IL10-/- (white symbol) mic. (B) Total number of RBCs as well as mature and immature RBCs in
the spleen of T. congolense infected (Day 45 p.i.) mice, Dashed line represents cytokine levels in
non-infected animals. Data are represented as mean of at least 3–5 mice per group ± SEM and
are representative of 2 independent experiments. (�: p�0.05, ���: p�0.005).
(TIF)
S6 Fig. Hepatocyte-IL10 deficiency does not alter the splenic RBC differentiation during
T. congolense infection. Percentage of the different erythroid populations (defined as
described in S3B Fig) in spleen of WT (black bar) and TgAlbCre-IL10-/- (open bar) mice at 40
days p.i. Results are representative of 2 independent experiments and shown as mean of 3 indi-
vidual mice ± SEM.
(TIF)
S7 Fig. Genotyping profile of TgAlbCre-IL10-/- and LysMCre-IL10-/- mice. Prior to per-
forming experiments mice were genotyped using the conditions described by the supplier
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(Jackson mice). Upper left panel: IL10fl/fl genotyping profile, Upper right panel: LysMCre gen-
otyping profile, Lower panel: TgAlbCre genotyping profile.
(TIF)
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